FY23- Medically Managed Intensive Inpatient Withdrawal Management Services (MMIWM)

The District of Columbia is seeking proposals for Fiscally Year 2023 Medically Managed Intensive Inpatient Withdrawal Management Services (MMIWM), a critical healthcare procurement designed to support substance abuse treatment. This contract opportunity, identified by the unique ID 66c8556e829eb5d86906f1dd, was posted on November 10, 2022, with proposals due by December 1, 2022. The procurement aims to secure comprehensive medical withdrawal management services for patients requiring intensive inpatient treatment for substance use disorders. Potential vendors must demonstrate extensive clinical expertise in managing complex medical withdrawal cases, including comprehensive patient assessment, individualized treatment planning, medical stabilization, and coordinated care transitions. Evaluation criteria are likely to include the vendor's clinical capabilities, staff qualifications, treatment protocols, patient outcomes tracking, and ability to provide evidence-based, patient-centered withdrawal management services.

While specific set-aside designations are not explicitly detailed in the provided information, District of Columbia procurement typically encourages participation from local, small, and disadvantaged business enterprises. Healthcare providers with specific credentials in addiction medicine, psychiatry, and intensive inpatient care will be most competitive for this opportunity. The contract appears focused on securing a qualified healthcare provider with robust infrastructure to manage medically complex substance abuse withdrawal cases. Though exact budget ranges are not specified, similar municipal healthcare service contracts often range from $500,000 to $2 million annually, depending on patient volume and service complexity. Potential respondents should be prepared to demonstrate comprehensive medical capabilities, staffing expertise, technological integration capacity, and a proven track record of successful patient outcomes in medically managed withdrawal settings.